Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

AMERICAN JOURNAL OF HEMATOLOGY

WILEY

1. Lymphoma Research Foundation
2. NIH [R01-CA160979]
3. Gabrielle's Angel Foundation (New York, NY)
4. Joan Harris Cancer Foundation (Boston, MA)
5. Brent Leahey Fund (Dana-Farber Cancer Institute)